Itonis Inc. (ITNS)
OTC PINK OTC PINK Primary 
SET Summary
Itonis Inc. (ITNS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Itonis Inc. ever had a stock split?
Itonis Inc. Profile
| Consumer Staples Distribution & Retail Industry | Consumer Staples Sector | Mark H. Cheung CEO | OTC PINK Exchange | 465733103 CUSIP |
| US Country | 3 Employees | - Last Dividend | 21 Mar 2007 Last Split | - IPO Date |
Overview
Itonis, Inc. is a development stage company with its focus on the production and marketing of over-the-counter and prescription homeopathic preparations aimed at treating common ailments and chronic diseases. Originally known as Kenshou, Inc., the company underwent a name change to Itonis, Inc. in December 2005 and has since been working towards bringing innovative health solutions to the market. Founded in 2005 and headquartered in Laguna Hills, California, Itonis, Inc. is dedicated to providing alternatives to traditional medication through its developed homeopathic and natural products.
Products and Services
- Over-The-Counter Homeopathic Preparations:
- Emesyl Product Line:
Itonis, Inc. focuses on the development and marketing of over-the-counter homeopathic preparations designed to alleviate common ailments and chronic diseases. These preparations aim to offer a natural and alternative solution to traditional medications, catering to individuals seeking homeopathic remedies.
The company is in the process of introducing its Emesyl product line, targeted at providing relief from mild to moderate nausea. Emesyl signifies Itonis, Inc.'s entry into the market with a specific solution for nausea relief, demonstrating the company's commitment to expanding its range of homeopathic remedies. A manufacturing order for the first batch of Emesyl products has already been placed, indicating the company’s move towards large-scale distribution.
